Simpson Thacher Represents Barclays in Bridge Financing for Boston Scientific’s Approximately $4.2 Billion Acquisition of BTG
The Firm is representing Barclays Bank PLC in connection with the bridge financing for Boston Scientific Corporation to finance its announced acquisition of BTG plc.
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Boston Scientific Corporation’s products and technologies are used to diagnose or treat a wide range of medical conditions, including cardiovascular, digestive, respiratory, urological, pelvic health and neurological conditions.